View printer-friendly version << Back

Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference

GAITHERSBURG, Md., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced Stanley C Erck, President and Chief Executive Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference.

Conference details are as follows:

Date: Tuesday, November 29, 2016
Time: 3:30 pm U.S. Eastern Time
Location: New York Palace Hotel, New York, New York
Live webcast:, “Investors”/ “Events”

A replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website,


Novavax, Inc.Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

Russo Partners, LLCDavid SchullTodd Davenport, Ph.D.

Primary Logo

Novavax, Inc.